Warren K. Laskey, MD, MPH
Disclosures: The author has disclosed no conflicts of interest. The form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterest Forms.do?msNum=M14-0874.
Requests for Single Reprints: Warren K. Laskey, MD, MPH, Division of Cardiology, Department of Internal Medicine, University of New Mexico, MSC10-5550, 1 University of New Mexico, Albuquerque, NM 87131; e-mail, email@example.com.
Author Contributions:Conception and design: W.K. Laskey.
Analysis and interpretation of the data: W.K. Laskey.
Drafting of the article: W.K. Laskey.
Critical revision of the article for important intellectual content: W.K. Laskey.
Final approval of the article: W.K. Laskey.
Obtaining of funding: W.K. Laskey.
Administrative, technical, or logistic support: W.K. Laskey.
Collection and assembly of data: W.K. Laskey.
Laskey WK. Drug-Eluting Stents: Boom or Bust?. Ann Intern Med. 2014;161:740–741. doi: https://doi.org/10.7326/M14-0874
Download citation file:
Published: Ann Intern Med. 2014;161(10):740-741.
Cardiology, Coronary Heart Disease, Percutaneous Coronary Intervention.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use